The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Regulatory News (FEVR)

Share Price Information for Fevertree (FEVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,149.00
Bid: 1,144.00
Ask: 1,149.00
Change: 12.00 (1.06%)
Spread: 5.00 (0.437%)
Open: 1,121.00
High: 1,149.00
Low: 1,121.00
Prev. Close: 1,137.00
FEVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FCA letter re Release of Preliminary Results

23 Mar 2020 10:59

RNS Number : 1873H
Fevertree Drinks PLC
23 March 2020
 

23rd March 2020

Fevertree Drinks plc

 ("Fever-Tree" or the "Group")

  

FCA letter re Temporary Moratorium on Release of Preliminary Results

The FCA issued guidance on 21 March 2020 requesting public companies to delay the announcement of Preliminary Results for at least two weeks, due to the challenges caused by the Coronavirus crisis. Consequently, while Fever-Tree intended to announce its Preliminary Results for the year ended 31 December 2019 on 24 March 2020, the Group will follow the FCA's request and confirms that it will defer the publication of its results.

Fever-Tree is a global business with revenue diversified across regions, channels and customers. Notwithstanding tough comparators in the UK, the Group has made a solid start to the new financial year, with trading in the first two months in line with the Board's expectations, with the US in particular seeing strong trading.

However, given the current high level of uncertainty it is too early to quantify the impact the COVID-19 crisis will have on the outturn for the remainder of the 2020 financial year and therefore the Board is not able to provide financial guidance at this stage.

Our focus, first and foremost, is on the health and wellbeing of our employees, customers and partners across all our regions. Whilst we will face challenges in the coming months, financially the Group is extremely secure. We are debt free, with a year-end cash position of £128m underpinned by strong cash flows. The Group's unique asset light, outsourced business model means we have a low fixed cost base, a small, dedicated team and the flexibility to manage the significant challenges ahead.

The Group will await further guidance from the FCA with regard to the timing of the publication of its Preliminary Results. 

For further information:

 

Fevertree Drinks plc  +44 (0)20 7349 4922

Tim Warrillow, Co-founder and CEO

Andy Branchflower, CFO

Oliver Winters, Communications & IR Director

 

Numis Securities - Nominated Adviser and Joint Broker +44 (0)20 7260 1000

Garry Levin

Matt Lewis

Hugo Rubinstein

 

Investec Bank plc - Joint Broker +44 (0)20 7597 5970

David Flin

Alex Wright

David Anderson 

 

Brunswick Group +44 (0) 20 7404 5959

Jonathan Glass

Fiona Micallef-Eynaud

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFLFEIVIIVFII
Date   Source Headline
4th Feb 20163:29 pmRNSHolding(s) in Company
27th Jan 20161:39 pmRNSHolding(s) in Company
26th Jan 201610:38 amRNSHolding(s) in Company
25th Jan 20167:00 amRNSTrading Update
23rd Dec 201510:01 amRNSHolding(s) in Company
30th Nov 20155:58 pmRNSHolding(s) in Company
30th Nov 201510:24 amRNSHolding(s) in Company
19th Nov 20155:00 pmRNSHolding(s) in Company
4th Nov 20157:00 amRNSTrading Update
16th Sep 20159:00 amRNSHolding(s) in Company
25th Aug 201510:17 amRNSHolding(s) in Company
3rd Aug 20153:41 pmRNSHolding(s) in Company
27th Jul 20157:00 amRNSInterim Results
9th Jul 20154:45 pmRNSHolding(s) in Company
9th Jul 20153:50 pmRNSHolding(s) in Company
9th Jul 20152:30 pmRNSHolding(s) in Company
8th Jul 20154:59 pmRNSSale of Ordinary Shares in Fever-Tree
8th Jul 20154:49 pmRNSDirector/PDMR Shareholding
8th Jul 20157:00 amRNSPre-Close Trading Statement
19th Jun 20155:35 pmRNSFever-Tree TR-1
29th May 20153:20 pmRNSHolding(s) in Company
7th May 20155:26 pmRNSResult of AGM
9th Apr 20157:00 amRNSHolding(s) in Company
7th Apr 20153:30 pmRNSHolding(s) in Company
7th Apr 20157:00 amRNSHolding(s) in Company
2nd Apr 20155:02 pmRNSSale of Ordinary Shares in Fever-Tree
1st Apr 20157:00 amRNS2014 Annual Report and Notice of AGM
23rd Mar 20157:00 amRNSPreliminary Results 2014
22nd Jan 20157:00 amRNSPre-Close Trading Statement
15th Jan 20154:17 pmRNSHolding(s) in Company
8th Jan 20153:05 pmRNSHolding(s) in Company
7th Jan 20159:26 amRNSHolding(s) in Company
23rd Dec 20147:00 amRNSNotice of pre-close Trading Statement
17th Nov 20144:18 pmRNSHolding(s) in Company
17th Nov 20144:16 pmRNSHolding(s) in Company
7th Nov 20147:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.